Jiaxue Wu

Years Active: 2020-2022
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Ting Shen, Ting Ni, Jiaxuan Chen, Haitao Chen, Xiaopin Ma, Guangwen Cao, Tianzhi Wu, Haisheng Xie, Bin Zhou, Gang Wei, Hexige Saiyin, Suqin Shen, Peng Yu, Qianyi Xiao, Hui Liu, Yuzheng Gao, Xidai Long, Jianhua Yin, Yanfang Guo, Jiaxue Wu, Gong-Hong Wei, Jinlin Hou, De-Ke Jiang
An enhancer variant at 16q22.1 predisposes to hepatocellular carcinoma via regulating PRMT7 expression. Nature communications 13 (1) (2022)
Wenqing Gao, Yuanyuan Li, Xuehe Liu, Sen Wang, Pucheng Mei, Zijun Chen, Kewei Liu, Suhua Li, Xue-Wei Xu, Jianhua Gan, Jiaxue Wu, Chaoneng Ji, Chen Ding, Xing Liu, Yuping Lai, Housheng Hansen He, Judy Lieberman, Hao Wu, Xiang-Jun Chen, Jixi Li
TRIM21 regulates pyroptotic cell death by promoting Gasdermin D oligomerization. Cell death and differentiation (2021)
Pucheng Mei, Feiyan Xie, Jiasong Pan, Sen Wang, Wenqing Gao, Rui Ge, Baocai Gao, Siqi Gao, Xiangjun Chen, Yongming Wang, Jiaxue Wu, Chen Ding, Jixi Li
E3 ligase TRIM25 ubiquitinates RIP3 to inhibit TNF induced cell necrosis. Cell death and differentiation 28 (10) (2021)
Huan Feng, Juan Liu, Yangyang Qiu, Yao Liu, Hexige Saiyin, Xiao Liang, Fen Zheng, Ying Wang, Deke Jiang, Ying Wang, Long Yu, Wei Su, Suqin Shen, Jiaxue Wu
RNA-binding motif protein 43 (RBM43) suppresses hepatocellular carcinoma progression through modulation of cyclin B1 expression. Oncogene 39 (33) (2020)

Jiaxue Wu.css-eqlu8i{font-size:small;padding-left:4px;}